JSE gains on Covid-19 vaccine optimism
US officials have said that vaccination could be rolled out by mid-December
24 November 2020 - 11:13
The JSE was firmer on Tuesday, with global peers mixed as investors pinned hopes for economic revival on Covid-19 vaccines.
The vaccine developed by AstraZeneca and Oxford University is the third major trial to report success after US-based Moderna and Pfizer with Germany's BioNTech, sending pandemic-weary investors to take on risk in hopes of a swift economic recovery...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.